明德生物:拟收购武汉必凯尔100%股权
Ge Long Hui·2025-12-30 10:44

Group 1 - The core point of the article is that Mingde Biological (002932.SZ) has signed a framework agreement with Bluefan Medical Co., Ltd. to acquire 100% equity of Wuhan Bikaier Rescue Supplies Co., Ltd. through cash payment [1] - The transaction is expected to constitute a major asset restructuring as defined by the regulations of the Major Asset Restructuring Management Measures for Listed Companies [1] - The acquisition will be conducted in cash and will not involve a restructuring listing or the issuance of shares by the listed company [1] Group 2 - The transaction does not constitute a related party transaction and will not lead to changes in the controlling shareholder or actual controller of the listed company [1] - The target company is one of the early adopters of international first aid concepts and technologies, primarily engaged in emergency rescue business centered around first aid kits, emergency equipment, and services [1]

eDiagnosis-明德生物:拟收购武汉必凯尔100%股权 - Reportify